Search results
Military chief survived strike, says Hamas, and ceasefire talks continue
Irish Examiner· 8 hours agoRolling coverage of the international stories of interest to our readers
Oklo’s nuclear order book shows potential of small reactors
Reuters· 5 days agoOklo is developing scalable nuclear power plants ranging from 15 MWe to 50 MWe based on liquid metal reactor technology that can run on both fresh and recycled fuel. Licensing and fuel
What will Labour do to the British constitution?
The New Statesman· 4 days agoAppearances can be deceptive in politics, but it seems unlikely that Keir Starmer’s new administration will go down in history as a beacon of democratic...
Venice nets £1.7m in tax pilot which critics say failed to deter day-trippers
Irish Examiner· 13 hours agoRolling coverage of the international stories of interest to our readers
Is NextEra Energy (NEE) a Good Quality Growth Stock?
Insider Monkey via Yahoo Finance UK· 6 days agoClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” second quarter 2024 investor letter. A...
Mother and son die in car crash while celebrating her beating cancer
Daily Mail· 5 days agoAccording to medical information, they are fine and are not in danger of dying! 'We kindly ask that...
Could Health Insurance Brokers Heal Our Broken Healthcare System?
Forbes· 6 days agoRefining the role of health insurance brokers could unlock a major augmentation of the US healthcare...
Reason For Our Health Care Crisis: Government
Forbes· 3 days agoThe old saw about health care in leftist quarters is this: “The United States is the only industrialized country without national health insurance.” The...
HepaStem: toward an alternative to liver transplantation
Nature· 3 days agoThe company provides an end-to-end solution backed by its strong track record in the field of liver diseases, its expertise in manufacturing and building the necessary supply
Augmented intelligence at the service of personalised medicine: how artificial intelligence is...
Nature· 3 days agoThe traditional drug discovery and development process contends with a high failure rate of clinical trials at phase 2 and 3 as patients do not respond the same way to a given treatment. MIMs ...